bromodeoxyuridine has been researched along with Severe Combined Immunodeficiency in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fukushima, S; Makino, S; Mori, S; Morimura, K; Nomura, T; Salim, EI; Wanibuchi, H; Yamamoto, S | 1 |
1 other study(ies) available for bromodeoxyuridine and Severe Combined Immunodeficiency
Article | Year |
---|---|
Low-dose-dependent carcinogenic potential of 2-amino-3-methylimidazo[4,5-f]quinoline in the immunodeficient (SCID) mouse colon.
Topics: Animals; Body Weight; Bromodeoxyuridine; Carcinogens; Colonic Neoplasms; Dose-Response Relationship, Drug; Female; Immunohistochemistry; Kidney; Liver; Male; Mice; Mice, SCID; Organ Size; Quinolines; Severe Combined Immunodeficiency | 1999 |